The EZER™ Carbapenemase Rapid Test is a lateral flow immunoassay designed for the rapid, qualitative detection and differentiation of five common carbapenemase types—NDM, KPC, OXA-48-like, IMP, and VIM—directly from pure bacterial colonies. It provides accurate results within just 15 minutes, enabling timely clinical decisions and infection control interventions.
Carbapenemase-producing organisms (CPOs), particularly Carbapenem-resistant Enterobacterales (CRE) and Pseudomonas aeruginosa, pose a critical threat in healthcare environments due to their resistance to nearly all available antibiotics. This Carbapenemase-targeted assay allows laboratory professionals to rapidly identify multidrug-resistant organisms (MDROs) on routine culture media such as blood agar and MacConkey agar.
The test uses two lateral flow strips for specific visual identification of each of the five enzymes. It requires no special instrumentation, only basic lab handling, making it an excellent fit for microbiology departments in hospitals, reference labs, and public health institutions.
With 100% sensitivity, specificity, and overall accuracy—validated against PCR and phenotypic methods—the EZER™ Carbapenemase Rapid Test is a powerful tool in antimicrobial stewardship and outbreak control.
Each EZER™ Carbapenemase Rapid Test kit includes:
20 individual test devices (2-strip format)
20 extraction tubes pre-filled with buffer
1 package insert with detailed instructions
The two-strip configuration allows for clear differentiation:
Strip 1: Detects NDM (N), KPC (K), OXA-48-like (O), with a control line (C)
Strip 2: Detects IMP (I) and VIM (V), with a separate control line (C)
The red lines that appear correspond to the presence of one or more carbapenemase-positive enzymes. A control line ensures the validity of each test.

Carbapenemases are β-lactamase enzymes that hydrolyze carbapenem antibiotics—often considered the last resort for treating Gram-negative infections. The most prevalent types include:
KPC (Class A)
NDM, VIM, IMP (Class B metallo-β-lactamases)
OXA-48-like (Class D)
These enzymes contribute to resistance in:
Enterobacterales, such as Klebsiella pneumoniae, E. coli
Non-fermenters, like Pseudomonas aeruginosa
Infections caused by carbapenemase-producing organisms (CPOs) are associated with high morbidity, mortality, and healthcare costs. Rapid detection is essential for implementing isolation measures, optimizing therapy, and preventing nosocomial outbreaks.
Developed by Genesis Biotech, the EZER™ test uses gold-conjugated monoclonal antibodies specific to each carbapenemase type. Validated against Xpert® Carba-R (Cepheid) and phenotypic AST methods, its performance is unmatched:
Sensitivity: 100%
Specificity: 100%
Accuracy: 100% (n=265)
NDM: 0.1 ng/mL
KPC: 0.5 ng/mL
OXA-48-like: 0.125 ng/mL
IMP: 0.125 ng/mL
VIM: 0.05 ng/mL
The test shows no cross-reactivity with 40+ non-target resistance mechanisms, including ESBLs, AmpC, and MBL variants not among the 5 detected. This makes it ideal for carbapenemase-positive identification with high confidence.
This is a visual immunochromatographic assay using a double-strip cassette:
Pick 3 colonies from 18–24h blood/MacConkey agar using a 1µL loop
Suspend in the provided extraction buffer
Vortex to homogenize
Apply 3 drops (80 µL) of extract to each sample well
Wait 15 minutes
Read red lines at designated positions (N, K, O, I, V, C)
Result Interpretation:
Positive: Line at C + at one or more of the enzyme lines
Negative: Line at C only, no enzyme line
Invalid: No control line visible – retest required
This Carbapenemase-targeted test is easy to read and does not require additional instrumentation.
The EZER™ Carbapenemase Rapid Test is ideal for:
Clinical microbiology labs performing MDR surveillance
Infection control units in hospitals
Reference and public health labs monitoring CRE spread
ICU and emergency settings needing rapid isolation decisions
By offering rapid, cost-effective, and accurate carbapenemase-positive screening, it plays a crucial role in antimicrobial resistance containment strategies.
It supports:
Early outbreak containment
Antimicrobial therapy optimization
Laboratory-based stewardship protocols
Product Catalogus
For any missing information or if you require additional details, please do not hesitate to contact us.